Author:
Grasch Jennifer L.,de Voest Jessica A.,Saade George R.,Hughes Brenna L.,Reddy Uma M.,Costantine Maged M.,Chien Edward K.,Tita Alan T.N.,Thorp John M.,Metz Torri D.,Wapner Ronald J.,Sabharwal Vishakha,Simhan Hyagriv N.,Swamy Geeta K.,Heyborne Kent D.,Sibai Baha M.,Grobman William A.,El-Sayed Yasser Y.,Casey Brian M.,Parry Samuel,
Abstract
OBJECTIVE:
To characterize breastfeeding behaviors and identify factors associated with breastfeeding initiation among people with hepatitis C virus (HCV) infection.
METHODS:
We conducted a secondary analysis of a multicenter observational cohort of pregnant people with singleton gestations and HCV seropositivity. This analysis includes individuals with data on breastfeeding initiation and excludes those with human immunodeficiency virus (HIV) co-infection. The primary outcome was self-reported initiation of breastfeeding or provision of expressed breast milk. Secondary outcomes included duration of breastfeeding. Demographic and obstetric characteristics were compared between those who initiated breastfeeding and those who did not to identify associated factors. Univariable and multivariable analyses were performed.
RESULTS:
Overall, 579 individuals (75.0% of participants in the parent study) were included. Of those, 362 (62.5%) initiated breastfeeding or provided breast milk to their infants, with a median duration of breastfeeding of 1.4 months (interquartile range 0.5–6.0). People with HCV viremia, defined as a detectable viral load at any point during pregnancy, were less likely to initiate breastfeeding than those who had an undetectable viral load (59.4 vs 71.9%, adjusted odds ratio [aOR] 0.61, 95% CI, 0.41–0.92). People with private insurance were more likely to initiate breastfeeding compared with those with public insurance or no insurance (80.0 vs 60.1%; aOR 2.43, 95% CI, 1.31–4.50).
CONCLUSION:
Although HCV seropositivity is not a contraindication to breastfeeding regardless of viral load, rates of breastfeeding initiation were lower among people with HCV viremia than among those with an undetectable viral load.
CLINICAL TRIAL REGISTRATION:
ClinicalTrials.gov, NCT01959321.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献